Literature DB >> 10922301

Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content.

R A Zager1.   

Abstract

Polyene antibiotic administration is limited by dose-dependent nephrotoxicity. The latter is believed to be mediated by polyene anchoring to plasma membrane cholesterol, resulting in pore formation, abnormal ion/solute flux, adenosine triphosphate (ATP) declines, and, ultimately, a loss of tubule viability. The relative nephrotoxicity of these agents and their liposomal preparations has remained poorly defined. Thus, freshly isolated mouse proximal tubules or cultured human proximal tubule (HK-2) cells were exposed to either nystatin, amphotericin B, or three different polyene liposomal preparations (Nyotran, AmBisome, or Abelcet; 4 to 64 microg/mL). The impact of these agents on (1) plasma membrane injury (sodium-driven ATP consumption, assessed by ATP-adenosine diphosphate [ADP] ratios); (2) cellular susceptibility to superimposed injury (chemical hypoxia or ferrous ammonium sulfate-mediated oxidative stress; assessed by lactate dehydrogenase release); and (3) membrane cholesterol, phospholipid, and ceramide expression was assessed. Amphotericin B was more cytotoxic than nystatin (approximately 25% to 50% greater ATP-ADP ratio declines). Most of this toxicity could be eliminated by polyene liposomal formulation. Nevertheless, the liposomal polyenes still fully sensitized tubule cells to superimposed chemical hypoxic (antimycin/deoxyglucose), but not oxidant, attack. Nystatin and amphotericin B caused acute increments in tubule sphingomyelin-phosphatidylcholine ratios and ceramide content (indicating an impact on the plasma membrane extending beyond the classic view of pore formation with ion flux). In conclusion, (1) nystatin is seemingly less cytotoxic than amphotericin B (in contrast to the prevailing clinical view); (2) liposomal formulation markedly decreases this cytotoxicity; (3) despite this reduced toxicity, liposomal polyenes are still able to render tubule cells more vulnerable to selected forms of superimposed injury; and (4) acute alterations in plasma membrane phospholipid and ceramide expression are previously unrecognized consequences and potential mediators of polyene-mediated tubular cell attack.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922301     DOI: 10.1053/ajkd.2000.8967

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  15 in total

1.  Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits.

Authors:  Andreas H Groll; Diana Mickiene; Vidmantas Petraitis; Ruta Petraitiene; Raul M Alfaro; Christine King; Stephen C Piscitelli; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

2.  Long open amphotericin channels revealed in cholesterol-containing phospholipid membranes are blocked by thiazole derivative.

Authors:  Oleg Ya Shatursky; Olexander V Romanenko; Nina H Himmelreich
Journal:  J Membr Biol       Date:  2014-01-09       Impact factor: 1.843

3.  The interaction of dipole modifiers with amphotericin-ergosterol complexes. Effects of phospholipid and sphingolipid membrane composition.

Authors:  Olga S Ostroumova; Svetlana S Efimova; Ekaterina V Mikhailova; Ludmila V Schagina
Journal:  Eur Biophys J       Date:  2014-02-23       Impact factor: 1.733

4.  Efficacy of 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrole-2-yl)-1-methylethyl pentanoate in a murine model of invasive aspergillosis.

Authors:  Rajesh Dabur; S K Diwedi; V Yadav; V Mishra; Rambir Singh; H Singh; G L Sharma
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 5.  Amphotericin B membrane action: role for two types of ion channels in eliciting cell survival and lethal effects.

Authors:  B Eleazar Cohen
Journal:  J Membr Biol       Date:  2010-11-18       Impact factor: 1.843

6.  C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells.

Authors:  Brandon C Wilcock; Matthew M Endo; Brice E Uno; Martin D Burke
Journal:  J Am Chem Soc       Date:  2013-06-03       Impact factor: 15.419

Review 7.  The Role of Signaling via Aqueous Pore Formation in Resistance Responses to Amphotericin B.

Authors:  B Eleazar Cohen
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

8.  In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines.

Authors:  Carlos G Leon; Jinkyung Lee; Karen Bartlett; Pavel Gershkovich; Ellen K Wasan; Jinying Zhao; John G Clement; Kishor M Wasan
Journal:  Lipids Health Dis       Date:  2011-08-20       Impact factor: 3.876

9.  Nontoxic antimicrobials that evade drug resistance.

Authors:  Stephen A Davis; Benjamin M Vincent; Matthew M Endo; Luke Whitesell; Karen Marchillo; David R Andes; Susan Lindquist; Martin D Burke
Journal:  Nat Chem Biol       Date:  2015-06-01       Impact factor: 15.040

10.  In vitro cytotoxicity and in vivo acute and chronic toxicity of Xanthii Fructus and its processed product.

Authors:  Jie Yu; Mei-Zhen Song; Jing Wang; Yun-Fei Li; Pei Lin; Lin Que; Zhaorigetu Bao
Journal:  Biomed Res Int       Date:  2013-11-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.